AzTrials
AzTrials

Obsessive-Compulsive DisorderNCT03918577

Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders

A study testing Caloric Vestibular Stimulation in people with Obsessive-Compulsive Disorder and Body Dysmorphic Disorders, run by Stanford University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study investigates whether caloric vestibular stimulation can modulate a measure of insight in obsessive-compulsive spectrum disorders. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Caloric Vestibular Stimulation
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
10 May 2022to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18-65
  • Primary diagnosis of Obsessive-Compulsive Disorder, Body Dysmorphic Disorder, Illness Anxiety Disorder or Somatic Symptom Disorder (excluding "with predominant pain")
  • Strongly held OCRD-related concerns meeting BABS score criterion.
  • No recent change in psychopharmacological treatment, if any
  • Capacity to provide informed consent

Who cannot join

  • Psychiatric or medical conditions (eg, vertigo, history of otological surgery) that might make participation unsafe
  • Pregnant or nursing women
  • Active or recent substance use

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pavithra Mukunda, MS contact

650-723-4095

ocdresearch@stanford.edu

Maria Filippou-Frye, MD, MBS contact

650-723-4095

ocdresearch@stanford.edu

United States1 site, 1 recruiting
  • Stanford University

    Stanford, California, 94304

    Pavithra Makunda, MS, 650-723-4095, ocdresearch@stanford.edu

    Sindu Menon, MBBS, 650-723-4095, ocdresearch@stanford.edu

    Recruiting

Other trials in United States

About this study

This study investigates whether caloric vestibular stimulation can modulate a measure of insight in obsessive-compulsive spectrum disorders.

Read the detailed description

Obsessive-compulsive and related disorders (OCRD), including obsessive compulsive disorder and body dysmorphic disorder, are chronic and disabling conditions characterized by recurrent intrusive thoughts and associated compulsive behaviors that affect millions of individuals in the US each year. Individuals affected by OCRD differ in insight, or the degree to which they understand their intrusive thoughts to reflect illness. Impairments in insight limit individuals' motivation to engage in care and predict worse outcome in those who access treatment.

This study seeks to explore whether unilateral stimulation of the vestibular system, which activates cortical areas hypothesized to underlie clinical insight, may beneficially modulate insight in individuals with OCRD.

Being tested
Caloric Vestibular Stimulation
Keywords
Caloric Vestibular Stimulation, Insight
Medical subject headings
Obsessive-Compulsive Disorder, Body Dysmorphic Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Caloric Vestibular StimulationOther

    Cold water creates a convection current in the semicircular canal of the vestibular apparatus, leading to brief (<3 min) and typically well tolerated sense of rotational movement. Similar stimulation is routinely used in standard vestibular diagnostic testing.

Study groups in NCT03918577
Study groupRoleWhat they receive
right cold caloric vestibular stimulationExperimentalOCRD participants in this arm will receive an approx 60 second infusion of distilled cold(4)c water in their right external ear canal, with before and after measures of OCRD symptom severity and insight.
Receives: Other: Caloric Vestibular Stimulation
left cold caloric vestibular stimulationExperimentalOCRD participants in this arm will receive an approx 60 second infusion of distilled cold(4)c water in their left external ear canal, with before and after measures of OCRD symptom severity and insight.
Receives: Other: Caloric Vestibular Stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in clinical insight as measured by the Brown Assessment of Beliefs (BABS).

    Changes in clinical insight will be rated using the BABS, a gold-standard measure for assessing multiple dimensions of clinical insight across psychiatric disorders. The BABS is a 24 point scale for which scores ≥13 suggest poor or absent insight.

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2019
  2. Study start10 May 2022
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
randomized, controlled crossover study
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03918577
Sponsor's protocol ID
45068
Status last verified
Jan 2026
First submitted
15 Apr 2019
Last updated
22 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Caloric Vestibular Stimulation in people with Obsessive-Compulsive Disorder and Body Dysmorphic Disorders, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pavithra Mukunda, MS (650-723-4095, ocdresearch@stanford.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in clinical insight as measured by the Brown Assessment of Beliefs (BABS). (time frame: 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in